Life Sciences Snapshot – Q2 2024 – A Quarterly Report on Financing Trends
21 minute read | June.26.2024
Partner
Los Angeles
David Gindler leads Orrick’s Life Sciences Sector. An experienced trial attorney, he focuses on intellectual property litigation and licensing, with a strong emphasis on trials of high-stakes patent and trade secret disputes in the life sciences field. David’s exceptional record has earned him repeat honors by Chambers USA. He has been Chambers-ranked for 15 years and is currently ranked Band 2 for Life Sciences: IP/Patent Litigation in both the USA Nationwide and California editions.
David has achieved extraordinary trial outcomes for both plaintiffs and defendants, including a $302 million verdict for breach of a research and license agreement covering foundational biotechnology, as well as defeating a $217 million damages claim in a patent dispute where liability had already been established in an earlier trial handled by a different law firm. David also negotiates complex intellectual property license agreements involving cutting-edge technologies and creative financial structures, frequently working on behalf of leading academic institutions.
David is a passionate supporter of the nonprofit performing arts community. He is currently a member of the boards of directors of the Los Angeles Master Chorale and the Antaeus Theatre Company. He is a past member of the boards of directors of the Los Angeles Philharmonic, Center Theatre Group, the Music Center, and Beth Morrison Projects.
David is a Member of the Litigation and Intellectual Property Law Sections of the American Bar Association, the State Bar of California and the Los Angeles County Bar Association. Mr. Gindler is also a member of the Federal Circuit Bar Association, the American Intellectual Property Law Association, and the Los Angeles Intellectual Property Law Association.
Select prior experience includes:
21 minute read | June.26.2024
4 minute read | November.15.2022